Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Edwards Lifesciences (EW) stocks in Canada
Learn how to easily invest in Edwards Lifesciences stocks.
Edwards Lifesciences is a medical devices business based in the US. Edwards Lifesciences stocks (EW.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $81.57 – an increase of 2.44% over the previous week. Edwards Lifesciences employs 17,300 staff and has a trailing 12-month revenue of around $5.4 billion.
How to buy Edwards Lifesciences stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EW. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
What's in this guide?
- Can I buy shares in Edwards Lifesciences?
- Has coronavirus impacted Edwards Lifesciences shares?
- Edwards Lifesciences shares summary
- Compare share dealing platforms
- Is Edwards Lifesciences stock a buy or sell?
- Edwards Lifesciences performance over time
- Is Edwards Lifesciences suitable for ethical investing?
- Are Edwards Lifesciences shares over-valued?
- Edwards Lifesciences's financials
- How volatile are Edwards Lifesciences shares?
- Does Edwards Lifesciences pay a dividend?
- Have Edwards Lifesciences shares ever split?
- Other common questions
Edwards Lifesciences stock price (NYSE:EW)Use our graph to track the performance of EW stocks over time.
Edwards Lifesciences shares at a glance
|Latest market close||$82.73|
|52-week range||$67.13 - $131.10|
|50-day moving average||$78.87|
|200-day moving average||$84.54|
|Wall St. target price||$87.45|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$2.44|
Buy Edwards Lifesciences stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Edwards Lifesciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Edwards Lifesciences price performance over time
Historical closes compared with the close of $82.73 from 2023-03-31
|1 week (2023-03-24)||2.44%|
|1 month (2023-03-02)||3.12%|
|3 months (2022-12-30)||10.88%|
|6 months (2022-09-30)||0.12%|
|1 year (2022-03-30)||-29.34%|
|2 years (2021-04-01)||-1.32%|
|3 years (2020-04-02)||184.86|
|5 years (2018-04-02)||135.45|
Is Edwards Lifesciences stock undervalued or overvalued?
Valuing Edwards Lifesciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Edwards Lifesciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Edwards Lifesciences's P/E ratio
Edwards Lifesciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Edwards Lifesciences shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Edwards Lifesciences's PEG ratio
Edwards Lifesciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0653. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Edwards Lifesciences's EBITDA
Edwards Lifesciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.9 billion.
The EBITDA is a measure of a Edwards Lifesciences's overall financial performance and is widely used to measure a its profitability.
Edwards Lifesciences financials
|Revenue TTM||$5.4 billion|
|Operating margin TTM||33.29%|
|Gross profit TTM||$4.3 billion|
|Return on assets TTM||13.34%|
|Return on equity TTM||26.14%|
|Market capitalisation||$50.1 billion|
TTM: trailing 12 months
Edwards Lifesciences's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Edwards Lifesciences's total ESG risk score
Total ESG risk: 21.68
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences's overall score of 21.68 (as at 01/01/2019) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Edwards Lifesciences's environmental score
Environmental score: 4.78/100
Edwards Lifesciences's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Edwards Lifesciences's social score
Social score: 13.43/100
Edwards Lifesciences's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Edwards Lifesciences's governance score
Governance score: 10.96/100
Edwards Lifesciences's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Edwards Lifesciences's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Edwards Lifesciences scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences has, for the most part, managed to keep its nose clean.
Edwards Lifesciences share dividends
We're not expecting Edwards Lifesciences to pay a dividend over the next 12 months.
Have Edwards Lifesciences's shares ever split?
Edwards Lifesciences's shares were split on a 3:1 basis on 1 June 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences shares which in turn could have impacted Edwards Lifesciences's share price.
Edwards Lifesciences share price volatility
Over the last 12 months, Edwards Lifesciences's shares have ranged in value from as little as $67.13 up to $131.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences's is 1.0056. This would suggest that Edwards Lifesciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Edwards Lifesciences overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Stocks similar to Edwards Lifesciences
Edwards Lifesciences in the news
Here's Why You Should Retain Avantor (AVTR) Stock for Now
NextGen's (NXGN) New Cloud-Based Solution to Improve Workflow
Edwards Lifesciences' (NYSE:EW) investors will be pleased with their respectable 79% return over the last five years
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Best new bank account offers in April 2023
Earn cash, rewards points, bonus interest rates and more with these new bank account offers and promotions.
Best bad credit loans in Saskatchewan
Find out where you can apply for some of the best bad credit loans in Saskatchewan, and learn how to increase your chances of getting approved.
5 sites like AutoTrader
Compare alternatives to AutoTrader in Canada.
Is GoHenry in Canada?
This spending app uses games and quizzes to teach kids about finances. GoHenry isn’t in Canada, but there are alternatives.
Finder Crypto Trading Platform Awards 2023
Find out how major crypto exchanges and brokers fared in 2023’s Crypto Trading Platform Awards.
Can a non-resident open a bank account in Canada?
Foreigners and non-residents entering Canada can open a bank account with the right identification.
Lemonade Finance review
Your guide to the exchange rates, fees and processing times of Lemonade Finance international money transfers.
Debit cards with no foreign transaction fees in Canada
Avoid or lower your international transaction fees when shopping online or travelling overseas.
ESG investing statistics
70% of Canadians are willing to make less on their investments to invest in a socially responsible way.
Loans like Advance America
These providers offer similar loans to Advance America for quick cash.
Ask an Expert
You must be logged in to post a comment.